Moderate glucose control results in less negative nitrogen balances in medical intensive care unit patients: a randomized, controlled study
© Hsu et al.; licensee BioMed Central Ltd. 2012
Received: 9 January 2012
Accepted: 5 April 2012
Published: 5 April 2012
Hyperglycemia and protein loss are common in critically ill patients. Insulin can be used to lower blood glucose and inhibit proteolysis. The impact of moderate insulin therapy on protein metabolism in critically ill patients has not been evaluated. We compared urinary nitrogen excretion, nitrogen balance, serum albumin concentrations, prealbumin concentrations, and clinical outcomes between patients receiving moderate insulin therapy (MIT) and conventional insulin therapy (CIT) in a medical ICU.
Patients were randomly divided into groups and treated with MIT (glucose target 120 to 140 mg/dl) or CIT (glucose target 180 to 200 mg/dl). Calories and protein intake were recorded each day. On days 3, 7 and 14, the 24-hour urinary nitrogen excretion, nitrogen balance, and serum albumin and prealbumin concentrations were measured. Clinical outcomes data were collected.
A total of 112 medical ICU patients were included, with 55 patients randomized to the MIT group and 57 patients randomized to the CIT group. Patients treated with MIT showed a trend towards increased nitrogen balance (P = 0.070), significantly lower urinary nitrogen excretion (P = 0.027), and higher serum albumin (P = 0.047) and prealbumin (P = 0.001) concentrations than patients treated with CIT. The differences between the two groups were most significant on day 3, when all factors showed significant differences (P < 0.05).
Moderate glucose control results in less negative nitrogen balances in medical ICU patients. Differences are more significant in the early stages compared with the late stages of critical illness.
Hyperglycemia, which is common in critically ill patients, occurs even in those patients who have not previously had diabetes [1, 2]. Critical illness is associated with increased circulating concentrations of proinflammatory cytokines, such as TNFα, IL-1, and IL-6, which may be important mediators of insulin resistance and hyperglycemia . Altered glucose metabolism results from the release of counter-regulatory hormones. Epinephrine and cortisol oppose the normal action of insulin, leading to increased adipose tissue lipolysis and skeletal muscle proteolysis . Reports state that pronounced hyperglycemia may lead to complications or a poor clinical outcome in such patients [5, 6]. The maintenance of normoglycemia using insulin therapy has been shown to significantly reduce morbidity and mortality in critically ill patients [5, 7, 8]. However, some studies failed to demonstrate improved outcome [9–12], and even a higher mortality rate was found  Intensive insulin therapy has been associated with a significantly higher risk of hypoglycemia [5, 7], resulting in concern regarding the safety of intensive insulin therapy. Glycemic control to a moderately tight range is not inferior to euglycemia and is clearly safer in critically ill patients . Patients with glucose levels of 130 mg/dl were reported to have a significantly lower incidence of infection and sepsis and a lower mortality rate .
Protein loss, which is also common in critically ill patients, is thought to arise from both increased proteolysis  and diminished protein synthesis . Protein wasting can negatively affect patient outcome . The use of insulin to promote an anabolic response during critical illness is a promising therapeutic approach. Animal studies have shown that strict insulin therapy normalizes organ nitrogen contents in diabetic rats . Woolfson and colleagues demonstrated that insulin has important protein-sparing effects in severely ill trauma patients . Shiozaki and colleagues showed that burn patients who received higher doses of insulin maintained a better nitrogen balance than a lower-dose group .
The purpose of this study was to investigate the differences in urinary nitrogen excretion, nitrogen balance, serum albumin and prealbumin concentrations, and clinical outcomes between moderate insulin therapy (MIT) and conventional insulin therapy (CIT) in critically ill patients.
Materials and methods
This study was a prospective, randomized, controlled trial conducted in an adult medical ICU of a tertiary medical center that has 1,235 beds in total, 59 of which are adult ICU beds. Trial and consent forms were approved by the Institutional Review Board of Kaohsiung Veterans General Hospital. The study was carried out between January 2006 and December 2006. Procedures were in accordance with the Helsinki Declaration.
After informed consent was obtained from patients or the next of kin, patients were randomly assigned to receive either MIT or CIT using software-generated simple randomization procedures (computerized random number) without blocking. Except for the interventionists (nurses and doctors), patients and other staff members were not informed of the group assignments. In the MIT group, continuous insulin infusion was started when the blood glucose concentrations exceeded 140 mg/dl in order to maintain a blood glucose concentration between 120 and 140 mg/dl. The insulin dose was adjusted using a neuro-fuzzy method; the insulin protocol is shown in Additional file 1. In the CIT group, continuous insulin infusion was delivered when blood glucose concentrations exceeded 200 mg/dl; the insulin dose was then adjusted to maintain a blood glucose concentration between 180 and 200 mg/dl.
All patients were fed either intravenously (total parenteral nutrition) or enterally starting the day after ICU admission. Enteral feeding was attempted as early as possible at the discretion of the attending physician. Once enteral feeding was started, patients were administered full-strength isotonic commercial formula Jevity (Abbott Laboratories, Brockville, ON, Canada) commencing at 20 ml/hour, and increased by 20 ml/hour every 4 hours to satisfy energy and protein requirements recommended by the clinical dietitian following the Canadian clinical practice guidelines for critically ill patients . All patients did not receive an albumin infusion during the study period.
At the time of randomization, demographic data and clinical characteristics were obtained. Blood glucose concentrations were measured upon admission and, subsequently, every 1 to 4 hours in all patients. Baseline serum albumin concentrations, prealbumin concentrations (Hitachi 7600; Hitachi, Tokyo, Japan), serum creatinine, and 24-hour urinary urea nitrogen (UUN) levels were collected and evaluated after beginning the study, and these data were collected and evaluated on days 3, 7, and 14 of the study. Additionally, we used full 24-hour urine collection rather than spot urine samples to determine the UUN. Blood cultures were obtained whenever the central body temperature exceeded 38.5°C or other clinical signs of sepsis were present. Blood transfusions were conducted according to the protocol when hemoglobin levels decreased to below 7 g/dl and were continued until target hemoglobin levels of 7 to 9 g/dl were attained. A higher hemoglobin level was required in patients with special circumstances; for example, myocardial ischemia, severe hypoxemia, acute hemorrhage, or lactic acidosis .
From the time of randomization to the time of discharge from the ICU, daily caloric and protein intakes, all blood glucose measurements, doses of insulin, red-blood-cell transfusions, blood cultures that were positive for pathogenic organisms, renal function, gastrointestinal bleeding, moderate hypoglycemia, and severe hypoglycemia were recorded.
Bloodstream infection was diagnosed either when a recognized pathogen was isolated from a blood culture, or in the presence of one of fever (> 38°C), chills, or hypotension and any of the following: a common skin contaminant isolated from two blood cultures that were drawn on separate occasions; a common skin contaminant isolated from the blood culture of a patient with an intravascular access device, and the physician instituted appropriate antimicrobial therapy; or a positive antigen blood test .
Gastrointestinal bleeding was defined as the presence of hematemesis, melena, bright red blood per rectum, or a coffee grounds-like substance that was aspirated from the feeding tube. Patients with hypoglycemia were defined as those who developed at least one episode of hypoglycemia. A moderate hypoglycemic event was defined as a blood glucose concentrations ≤ 60 and > 40 mg/dl. A severe hypoglycemic event was defined as blood glucose concentration ≤ 40 mg/dl.
The difference in daily insulin dose between the two groups was the total mean insulin dose of the MIT group minus the total mean insulin dose of the CIT group on the same day.
Primary outcomes included 24-hour UUN levels, nitrogen balance, serum albumin concentrations, and prealbumin concentrations. Secondary outcomes included ICU days, ventilator days, hospital days, acute renal injury, bloodstream infection, blood transfusions, gastrointestinal bleeding, moderate hypoglycemia, severe hypoglycemia, and hospital mortality rate.
All data were analyzed by SPSS version 12.0 (SPSS, Inc., Chicago, IL, USA). Data are presented as the mean ± standard deviation, median (interquartile range), or number (percentage). All data were analyzed according to the intention-to-treat principle. To detect differences of nitrogen balance using a two-sided 5% significance level and a power of 85% when the difference and standard deviation were equal to 0.80 and 1.97, a sample size of 55 patients per group was necessary. This value was based on previous studies involving nitrogen balance and different doses of insulin treatment in a burn ICU . Primary outcomes, such as 24-hour UUN levels, nitrogen balance, serum albumin concentrations, and prealbumin concentrations were analyzed with a generalized linear model for repeated measures using dummy variables. Student's t test was used to compare continuous variables with normally distributed data. Wilcoxon's rank-sum tests were used to compare continuous variables with non-normally distributed data. Chi-square tests were used to compare dichotomous variables. All P values were two-tailed. P < 0.05 was considered significant.
Demographic data for all patients
MIT group (n= 55)
CIT group (n= 57)
Primary ICU admitting diagnosis
Gastrointestinal or liver
Hematologic or oncologic
68.1 ± 16.3
70.4 ± 12.1
Body weight (kg)
61.4 ± 9.6
62.5 ± 9.8
Body mass index (kg/m2)
23.6 ± 3.0
23.9 ± 3.8
History of diabetes
Previous corticosteroid treatment
Use of inotropes
APACHE II score
20 (17 to 25)
21 (16.5 to 26.5)
Patients with total parenteral nutrition
Intake of nutrients
54.3 ± 0.2
54.4 ± 0.2
16.4 ± 0.1
16.4 ± 0.2
29.3 ± 0.2
29.2 ± 0.8
Blood glucose (mg/dl)
229.2 ± 39.3
231.1 ± 52.1
Serum hemoglobin (g/dl)
10.9 ± 2.2
10.8 ± 2.3
Serum ALT (U/l)
59.1 ± 79.3
63.8 ± 83.0
Serum total bilirubin (mg/dl)
1.1 ± 0.4
1.2 ± 0.4
UUN (g/BSA/24 hours)
7.0 ± 3.7
6.7 ± 3.8
Nitrogen balance (g/BSA/day)
-4.8 ± 5.9
-4.7 ± 4.5
Serum albumin (mg/dl)
1,949.9 ± 376.0
1,955.4 ± 506.5
Serum prealbumin (mg/dl)
11.3 ± 5.2
11.2 ± 4.5
Nutrition and blood glucose control
MIT group (n= 55)
CIT group (n= 57)
Mean blood glucose (mg/dl)
125.3 ± 17.8
199.9 ± 30.2
Daily dose of insulin (unit/day)
82 (69 to 111)
37 (26 to 44)
14 (9 to 19)
15 (11 to 26)
20 (11 to 30)
23 (11 to 43.5)
27 (15 to 36)
32 (18.5 to 51.3)
Acute renal injury
Red-blood-cell blood transfusion
Number of mild hypoglycemia
Rate of moderate hypoglycemia per 100 treatment days
Number of severe hypoglycemia
Rate of severe hypoglycemia per 100 treatment days
Hospital mortality rate
There were no statistically significant differences in ICU days, ventilator days, hospital days, rate of acute renal injury, bloodstream infection, red-blood-cell transfusion, and gastrointestinal bleeding in the two groups (Table 2).
Moderate hypoglycemia (blood glucose levels ≤ 60 mg/dl and > 40 mg/dl) occurred more often in the MIT group than in the CIT group, but this difference was not statistically significant (18.2% vs. 10.5%, P = 0.10; 2.4 episodes vs. 1.5 episodes per 100 treatment days, P = 0.18) (Table 2). The CIT group also exhibited a lower rate of severe hypoglycemia (blood glucose levels ≤ 40 mg/dl), but the difference was not significant (3.6% vs. 1.8%, P = 0.53; 0.3 episodes vs. 0.2 episodes per 100 treatment days, P = 0.44). No hemodynamic deterioration, convulsions, or neurological sequelae were noted in association with any hypoglycemic event in either group.
Patients with MIT had a trend for lower hospital mortality rate than that of patients with CIT, but they did not reach a statistically significant difference.
The results of this study showed that MIT could significantly improve nitrogen balance in the early stages of critical illness. Patients treated with MIT had significantly lower urinary nitrogen excretion and higher serum albumin and prealbumin concentrations than patients treated with CIT.
In the present study, both groups showed a negative nitrogen balance during the study period. Although the nitrogen balance was negative, both groups showed improvement during the study period. Protein is rapidly broken down in critically ill patients who are subjected to high stress . Hypermetabolism in patients under stress is associated with an increased negative nitrogen balance, and a positive nitrogen balance is difficult to attain in hypermetabolic patients . Equilibrium between energy intake and energy expenditure, early feeding, and a high-protein diet may improve nitrogen balance [30–32]. In this study, nitrogen balance was improved using moderate glucose control. This improvement may have arisen from higher dose insulin administered to the MIT group during the hospital course. Higher infused doses of insulin can result in a marked reduction in UUN excretion and a better nitrogen balance .
Differences in nitrogen balance between the two treatment groups were significant in the early stages of critical illness, but decreased over time. This observation may be related to the insulin dose. Differences in insulin dose between the two groups were more significant in the early stages than in the late stages.
The effect of insulin on protein metabolism appears primarily to be due to inhibition of proteolysis [33–35], although increased protein synthesis has been reported . In healthy subjects, insulin inhibits proteolysis in a dose-dependent manner . Insulin binding to its receptors activates the insulin receptor substrate pathway, leading to activation of protein kinase; protein kinase B modulates enzyme activities that affect nitric oxide generation and control protein metabolism .
Insulin also has an anabolic effect that is beneficial to critically ill patients; it may increase levels of insulin-like growth factor (IGF)-1, a mediator of anabolic growth hormone action, and decrease hepatic synthesis of IGF-1 binding protein, leading to the increased bioavailability of IGF-1 . In a study involving rats, IGF-1 administration significantly improved nitrogen balance .
Critical illness is characterized by hypermetabolism and catabolism, leading to peripheral protein waste [41, 42]. Proinflammatory mediators enhance catabolism and hypermetabolism by inhibition of the growth hormone-IGF-I-insulin axis [43–45]. Insulin improves hypermetabolism by affecting proinflammatory cytokine production and hepatic signal transcription factor expression ; it attenuates the inflammatory response by decreasing the proinflammatory cascade and increasing the anti-inflammatory cascade. By decreasing proinflammatory mediators, liver constitutive proteins such as albumin and prealbumin are increased . Inflammation reduces the albumin concentration by decreasing its rate of synthesis and increasing transfer of albumin out of the vascular compartment .
Although our data and previous studies have shown that insulin benefits protein metabolism, the extent to which the benefit is derived from the correction of hyperglycemia as opposed to the direct effects of insulin remains unclear . Van den Berghe and colleagues revealed that the lowering of blood glucose levels rather than the amount of infused insulin is related to the effects of insulin therapy on morbidity . Acute hyperglycemia enhances proteolysis in the entire body during hyperinsulinemia in normal men . Additionally, Whyte and colleagues demonstrated that the administration of insulin which resulted in supraphysiological concentrations did not attenuate protein breakdown and had no effect on the net protein balance in critically ill patients .
For patients receiving total parenteral nutrition, glucose and lipid ratios influence the nitrogen balance. A previous study showed that total parenteral nutrition at a glucose/lipid ratio of 50/50 induced a significantly higher nitrogen balance than an 80/20 ratio with an isocaloric isonitrogenous parenteral nutrition formula . In our study, few patients received total parenteral nutrition and they had a similar glucose/lipid ratio; thus, the glucose/lipid ratio is not a confounding factor for maintaining nitrogen balance.
A meta-analysis study showed that intensive insulin therapy has no advantage in reducing the mortality rate, but significantly increases the risk of hypoglycemia . Our study demonstrated that most patients with hypoglycemia have a moderate form; severe hypoglycemia was rarely observed. Target glucose levels in our study were 120 to 140 mg/dl, which was higher than those in intensive insulin therapy studies that had a target below 110 mg/dl [5, 8]. The rate of severe hypoglycemia in the intensive insulin therapy ranged from 5.1 to 28.6% [5, 9–13]. The rate of severe hypoglycemia was lower in our study (3.6%) compared with previous studies that adopted intensive glucose control. Moderate glucose control was safer than intensive glucose control regarding severe hypoglycemia.
There are some limitations to our study. First, this was a single-center study limited to medical ICU patients without chronic renal loss. These results do not represent all critically ill patients. Second, our study was not double-blind because safe insulin titration required the monitoring of blood glucose levels. Doctors and nurses should be aware of target glucose control levels. All patients did follow the same protocol, however, except for those following the glucose control protocol. Third, the study group was only moderately sized. Some parameters, such as clinical outcomes, did not show a significant difference due to the small sample size. Further studies are needed to examine larger sample sizes.
Patients treated with MIT had significantly lower urinary nitrogen excretion and higher serum albumin and prealbumin concentrations compared with patients treated with CIT. Moderate glucose control can result in a less negative nitrogen balance in medical ICU patients. This difference was more significant in the early stages compared with the late stages of critical illness.
Patients treated with MIT had significantly lower urinary nitrogen excretion and higher serum albumin and prealbumin concentrations than patients treated with CIT.
Moderate glucose control can result in a less negative nitrogen balance; this may be related to insulin.
The difference of nitrogen balance between MIT and CIT was more significant in the early stages compared with the late stages of critical illness in medical ICU patients.
conventional insulin therapy
insulin-like growth factor
moderate insulin therapy
tumor necrosis factor
urinary urea nitrogen.
The authors would like to thank the medical staff (physicians, nurses and dietitians) in the ICUs of Kaohsiung Veterans General Hospital for their assistance in this study. Financial support was received from Kaohsiung Veterans General Hospital, No. VGHKS 95-070 (C-WH received an academic research fund from Kaohsiung Veterans General Hospital).
- Levetan CS, Passaro M, Jablonski K, Kass M, Ratner RE: Unrecognized diabetes among hospitalized patients. Diabetes Care 1998, 21: 246-249. 10.2337/diacare.21.2.246View ArticlePubMedGoogle Scholar
- Umpierrez GE, Isaacs SD, Bazargan N, You X, Thaler LM, Kitabchi AE: Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J Clin Endocrinol Metab 2002, 87: 978-982. 10.1210/jc.87.3.978View ArticlePubMedGoogle Scholar
- Mizock BA: Alterations in fuel metabolism in critical illness: hyperglycaemia. Best Pract Res Clin Endocrinol Metab 2001, 15: 533-551. 10.1053/beem.2001.0168View ArticlePubMedGoogle Scholar
- Robinson LE, van Soeren MH: Insulin resistance and hyperglycemia in critical illness: role of insulin in glycemic control. AACN Clin Issues 2004, 15: 45-62. 10.1097/00044067-200401000-00004View ArticlePubMedGoogle Scholar
- Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R: Intensive insulin therapy in the critically ill patients. N Engl J Med 2001, 345: 1359-1367. 10.1056/NEJMoa011300View ArticlePubMedGoogle Scholar
- McCowen KC, Malhotra A, Bistrian BR: Stress-induced hyperglycemia. Crit Care Clin 2001, 17: 107-124. 10.1016/S0749-0704(05)70154-8View ArticlePubMedGoogle Scholar
- Van den Berghe G, Wouters PJ, Bouillon R, Weekers F, Verwaest C, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P: Outcome benefit of intensive insulin therapy in the critically ill: insulin dose vs. glycemic control. Crit Care Med 2003, 31: 359-366. 10.1097/01.CCM.0000045568.12881.10View ArticlePubMedGoogle Scholar
- Van den Berghe G, Wilmer A, Hermans G, Meersseman W, Wouters PJ, Milants I, Van Wijngaerden E, Bobbaers H, Bouillon R: Intensive insulin therapy in the medical ICU. N Engl J Med 2006, 354: 449-461. 10.1056/NEJMoa052521View ArticlePubMedGoogle Scholar
- Brunkhorst FM, Engel C, Bloos F, Meier-Hellmann A, Ragaller M, Weiler N, Moerer O, Gruendling M, Oppert M, Grond S, Olthoff D, Jaschinski U, John S, Rossaint R, Welte T, Schaefer M, Kern P, Kuhnt E, Kiehntopf M, Hartog C, Natanson C, Loeffler M, Reinhart K, German Competence Network Sepsis (SepNet): Intensive insulin therapy and pentastarch resuscitation in severe sepsis. N Engl J Med 2008, 358: 125-139. 10.1056/NEJMoa070716View ArticlePubMedGoogle Scholar
- De La Rosa Gdel C, Donado JH, Restrepo AH, Quintero AM, González LG, Saldarriaga NE, Bedoya M, Toro JM, Velásquez JB, Valencia JC, Arango CM, Aleman PH, Vasquez EM, Chavarriaga JC, Yepes A, Pulido W, Cadavid CA, Grupo de Investigacion en Cuidado intensivo GICI-HPTU: Strict glycaemic control in patients hospitalised in a mixed medical and surgical intensive care unit: a randomised clinical trial. Crit Care 2008, 12: R120. 10.1186/cc7017View ArticlePubMedGoogle Scholar
- Arabi YM, Dabbagh OC, Tamim HM, Al-Shimemeri AA, Memish ZA, Haddad SH, Syed SJ, Giridhar HR, Rishu AH, Al-Daker MO, Kahoul SH, Britts RJ, Sakkijha MH: Intensive versus conventional insulin therapy: a randomized controlled trial in medical and surgical critically ill patients. Crit Care Med 2008, 36: 3190-3197. 10.1097/CCM.0b013e31818f21aaView ArticlePubMedGoogle Scholar
- Preiser JC, Devos P, Ruiz-Santana S, Mélot C, Annane D, Groeneveld J, Iapichino G, Leverve X, Nitenberg G, Singer P, Wernerman J, Joannidis M, Stecher A, Chioléro R: A prospective randomised multi-centre controlled trial on tight glucose control by intensive insulin therapy in adult intensive care units: the Glucontrol study. Intensive Care Med 2009, 35: 1738-1748. 10.1007/s00134-009-1585-2View ArticlePubMedGoogle Scholar
- Finfer S, Chittock DR, Su SY, Blair D, Foster D, Dhingra V, Bellomo R, Cook D, Dodek P, Henderson WR, Hébert PC, Heritier S, Heyland DK, McArthur C, McDonald E, Mitchell I, Myburgh JA, Norton R, Potter J, Robinson BG, Ronco JJ: Intensive versus conventional glucose control in critically ill patients. N Engl J Med 2009, 360: 1283-1297.View ArticlePubMedGoogle Scholar
- Bhamidipati CM, LaPar DJ, Stukenborg GJ, Morrison CC, Kern JA, Kron IL, Ailawadi G: Superiority of moderate control of hyperglycemia to tight control in patients undergoing coronary artery bypass grafting. J Thorac Cardiovasc Surg 2011, 141: 543-551. 10.1016/j.jtcvs.2010.10.005PubMed CentralView ArticlePubMedGoogle Scholar
- Jeschke MG, Kraft R, Emdad F, Kulp GA, Williams FN, Herndon DN: Glucose control in severely thermally injured pediatric patients: what glucose range should be the target? Ann Surg 2010, 252: 521-528.PubMedGoogle Scholar
- Hasselgren PO, James JH, Benson DW, Hall-Angerås M, Angerås U, Hiyama DT, Li S, Fischer JE: Total and myofibrillar protein breakdown in different types of rat skeletal muscle: effects of sepsis and regulation by insulin. Metabolism 1989, 38: 634-640. 10.1016/0026-0495(89)90100-5View ArticlePubMedGoogle Scholar
- Vary TC, Kimball SR: Sepsis-induced changes in protein synthesis: differential effects on fast- and slow-twitch muscles. Am J Physiol 1992, 262: C1513-C1519.PubMedGoogle Scholar
- Btaiche IF, Chan LN, Pleva M, Kraft MD: Critical illness, gastrointestinal complications, and medication therapy during enteral feeding in critically ill adult patients. Nutr Clin Pract 2010, 25: 32-49. 10.1177/0884533609357565View ArticlePubMedGoogle Scholar
- Almdal TP, Vilstrup H: Strict insulin therapy normalises organ nitrogen contents and the capacity of urea nitrogen synthesis in experimental diabetes in rats. Diabetologia 1988, 31: 114-118. 10.1007/BF00395558View ArticlePubMedGoogle Scholar
- Woolfson AM, Heatley RV, Allison SP: Insulin to inhibit protein catabolism after injury. N Engl J Med 1979, 300: 14-17. 10.1056/NEJM197901043000104View ArticlePubMedGoogle Scholar
- Shiozaki T, Tasaki O, Ohnishi M, Nishimura T, Hiraide A, Shimazu T, Yoshioka T, Sugimoto H: Paradoxical positive nitrogen balance in burn patients receiving high-dose administration of insulin for nutritional care. Surgery 1997, 122: 527-533. 10.1016/S0039-6060(97)90124-0View ArticlePubMedGoogle Scholar
- Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P, Acute Dialysis Quality Initiative Workgroup: Acute renal failure - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) group. Crit Care 2004, 8: R204-R212. 10.1186/cc2872PubMed CentralView ArticlePubMedGoogle Scholar
- Heyland DK, Dhaliwal R, Drover JW, Gramlich L, Dodek P, Canadian Critical Care Clinical Practice Guidelines Committee: Canadian clinical practice guidelines for nutrition support in mechanically ventilated, critically ill adults patients. JPEN J Parenter Enteral Nutr 2003, 27: 355-373. 10.1177/0148607103027005355View ArticlePubMedGoogle Scholar
- Dellinger RP, Carlet JM, Masur H, Gerlach H, Calandra T, Cohen J, Gea-Banacloche J, Keh D, Marshall JC, Parker MM, Ramsay G, Zimmerman JL, Vincent JL, Levy MM, Surviving Sepsis Campaign Management Guideline Committee: Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock. Crit Care Med 2004, 32: 858-873. 10.1097/01.CCM.0000117317.18092.E4View ArticlePubMedGoogle Scholar
- Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G, International Sepsis Definitions Conference: 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Intensive Care Med 2003, 29: 530-538.View ArticlePubMedGoogle Scholar
- Cockcroft DW, Gault MH: Prediction of creatinine clearance from serum creatinine. Nephron 1976, 16: 31-41. 10.1159/000180580View ArticlePubMedGoogle Scholar
- Garner JS, Jarvis WR, Emori TG, Horan TC, Hughes JM: CDC definitions for nosocomial infections, 1988. Am J Infect Control 1988, 16: 128-140. 10.1016/0196-6553(88)90053-3View ArticlePubMedGoogle Scholar
- Blackburn GL, Bistrian BR, Maini BS, Schlamm HT, Smith MF: Nutritional and metabolic assessment of the hospitalized patient. JPEN J Parenter Enteral Nutr 1977, 1: 11-22. 10.1177/014860717700100111View ArticlePubMedGoogle Scholar
- Pingleton SK: Nutrition in chronic critical illness. Clin Chest Med 2001, 22: 149-163. 10.1016/S0272-5231(05)70031-9View ArticlePubMedGoogle Scholar
- Japur CC, Monteiro JP, Marchini JS, Garcia RW, Basile-Filho A: Can an adequate energy intake be able to reverse the negative nitrogen balance in mechanically ventilated critically ill patients? J Crit Care 2010, 25: 445-450. 10.1016/j.jcrc.2009.05.009View ArticlePubMedGoogle Scholar
- Jivnani S, Iyer S, Umakumar K, Gore MA: Impact of enteral nutrition on nitrogen balance in patients of trauma. J Emerg Trauma Shock 2010, 3: 109-114. 10.4103/0974-2700.62101PubMed CentralView ArticlePubMedGoogle Scholar
- Bellomo R, Seacombe J, Daskalakis M, Farmer M, Wright C, Parkin G, Boyce N: A prospective comparative study of moderate versus high protein intake for critically ill patients with acute renal failure. Ren Fail 1997, 19: 111-120. 10.3109/08860229709026265View ArticlePubMedGoogle Scholar
- Castellino P, Luzi L, Simonson DC, Haymond M, DeFronzo RA: Effect of insulin and plasma amino acid concentrations on leucine metabolism in man. Role of substrate availability on estimates of whole body protein synthesis. J Clin Invest 1987, 80: 1784-1793. 10.1172/JCI113272PubMed CentralView ArticlePubMedGoogle Scholar
- Fukagawa NK, Minaker KL, Rowe JW, Goodman MN, Matthews DE, Bier DM, Young VR: Insulin-mediated reduction of whole body protein breakdown. Dose-response effects on leucine metabolism in postabsorptive men. J Clin Invest 1985, 76: 2306-2311. 10.1172/JCI112240PubMed CentralView ArticlePubMedGoogle Scholar
- Nair KS, Ford GC, Ekberg K, Fernqvist-Forbes E, Wahren J: Protein dynamics in whole body and in splanchnic and leg tissues in type I diabetic patients. J Clin Invest 1995, 95: 2926-2937. 10.1172/JCI118000PubMed CentralView ArticlePubMedGoogle Scholar
- Biolo G, Declan Fleming RY, Wolfe RR: Physiologic hyperinsulinemia stimulates protein synthesis and enhances transport of selected amino acids in human skeletal muscle. J Clin Invest 1995, 95: 811-819. 10.1172/JCI117731PubMed CentralView ArticlePubMedGoogle Scholar
- Tessari P, Inchiostro S, Biolo G, Trevisan R, Fantin G, Marescotti MC, Iori E, Tiengo A, Crepaldi G: Differential effects of hyperinsulinemia and hyperaminoacidemia on leucine-carbon metabolism in vivo . Evidence for distinct mechanisms in regulation of net amino acid deposition. J Clin Invest 1987, 79: 1062-1069. 10.1172/JCI112919PubMed CentralView ArticlePubMedGoogle Scholar
- Van den Berghe G: How dose blood glucose control with insulin save lives in intensive care? J Clin Invest 2004, 114: 1187-1195.PubMed CentralView ArticlePubMedGoogle Scholar
- Brismar K, Fernqvist-Forbes E, Wahren J, Hall K: Effect of insulin on the hepatic production of insulin-like growth factor-binding protein-1 (IGFBP-1), IGFBP-3, and IGF-I in insulin-dependent diabetes. J Clin Endocrinol Metab 1994, 79: 872-878. 10.1210/jc.79.3.872PubMedGoogle Scholar
- Núñez M, Urdaneta E, Santidrián S: Effect of insulin-like growth factor-I on nitrogen balance and intestinal galactose transport in rats with moderate liver cirrhosis. Br J Nutr 2003, 90: 929-937. 10.1079/BJN2003974View ArticlePubMedGoogle Scholar
- Rennie MJ: Muscle protein turnover and the wasting due to injury and disease. Br Med Bull 1985, 41: 257-264.PubMedGoogle Scholar
- Wilmore DW: Catabolic illness. Strategies for enhancing recovery. N Engl J Med 1991, 325: 695-702. 10.1056/NEJM199109053251005View ArticlePubMedGoogle Scholar
- Van den Berghe G, de Zegher F, Veldhuis JD, Wouters P, Awouters M, Verbruggen W, Schetz M, Verwaest C, Lauwers P, Bouillon R, Bowers CY: The somatotropic axis in critical illness: effect of continuous growth hormone (GH)-releasing hormone and GH-relaesing peptide-2 infusion. J Clin Endocrinol Metab 1997, 82: 590-599. 10.1210/jc.82.2.590PubMedGoogle Scholar
- Frost RA, Lang CH, Gelato MC: Transient exposure of human myoblasts to tumor necrosis factor-alpha inhibits serum and insulin-like growth factors-I stimulated protein synthesis. Endocrinology 1997, 138: 4153-4159. 10.1210/en.138.10.4153PubMedGoogle Scholar
- Timmins AC, Cotterill AM, Hughes SC, Holly JM, Ross RJ, Blum W, Hinds CJ: Critical illness is associated with low circulating concentrations of insulin-like growth factors-I and -II, alterations in insulin-like growth hormone factors binding proteins, and induction of an insulin-like growth factor binding protein 3 protease. Crit Care Med 1996, 24: 1460-1466. 10.1097/00003246-199609000-00006View ArticlePubMedGoogle Scholar
- Jeschke MG, Einspanier R, Klein D, Jauch KW: Insulin attenuates the systemic inflammatory response to thermal trauma. Mol Med 2002, 8: 443-450.PubMed CentralPubMedGoogle Scholar
- Jeschke MG, Klein D, Herndon DN: Insulin treatment improves the systemic inflammatory reaction to severe trauma. Ann Surg 2004, 239: 553-560. 10.1097/01.sla.0000118569.10289.adPubMed CentralView ArticlePubMedGoogle Scholar
- Don BR, Kaysen G: Serum albumin: relationship to inflammation and nutrition. Semin Dial 2004, 17: 432-437. 10.1111/j.0894-0959.2004.17603.xView ArticlePubMedGoogle Scholar
- Wolfe RR: Regulation of skeletal muscle protein metabolism in catabolic states. Curr Opin Clin Nutr Metab Care 2005, 8: 61-65. 10.1097/00075197-200501000-00009View ArticlePubMedGoogle Scholar
- Flakoll PJ, Hill JO, Abumrad NN: Acute hyperglycemia enhances proteolysis in normal man. Am J Physiol 1993, 265: E715-E721.PubMedGoogle Scholar
- Whyte MB, Jackson NC, Shojaee-Moradie F, Treacher DF, Beale RJ, Jones RH, Umpleby AM: Metabolic effects of intensive insulin therapy in critically ill patients. Am J Physiol Endocrinol Metab 2010, 298: E697-E705. 10.1152/ajpendo.00407.2009View ArticlePubMedGoogle Scholar
- Boulétreau P, Chassard D, Allaouchiche B, Dumont JC, Auboyer C, Bertin-Maghit M, Bricard H, Ecochard R, Rangaraj J, Chambrier C, Schneid C, Cynober L: Glucose-lipid ratio is a determinant of nitrogen balance during total parenteral nutrition in critically ill patients: a prospective, randomized, multicenter blind trial with an intention-to-treat analysis. Intensive Care Med 2005, 31: 1394-1400. 10.1007/s00134-005-2771-5View ArticlePubMedGoogle Scholar
- Wiener RS, Wiener DC, Larson RJ: Benefits and risks of tight glucose control in critically ill adults: a meta-analysis. JAMA 2008, 300: 933-944. 10.1001/jama.300.8.933View ArticlePubMedGoogle Scholar
This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.